This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Syneron Medical Ltd (ELOS)

NASDAQ: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) 1.55M -2.34M -51.75M 0.00
Operating Gains/Losses 0.00 -758.00K 1.56M 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -8.63M -5.92M -3.82M 12.11M
(Increase) Decrease in Inventories -10.86M -7.07M -8.58M 13.18M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 2.24M -2.13M 4.47M -1.99M
(Decrease) Increase In Other Current Liabilities -37.00K -11.39M -478.00K 335.00K
(Increase) Decrease In Other Working Capital -14.31M 710.00K -231.00K -3.77M
Other Non-Cash Items 1.01M 6.84M 4.08M -31.37M
Net Cash From Continuing Operations -21.95M -11.08M -44.70M -2.12M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -21.95M -11.08M -44.70M -2.12M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 63.29M 0.00 214.14M
Purchases of Property, Plant & Equipment -3.66M -1.99M -2.12M -887.00K
Acquisitions -320.00K -15.06M 0.00 21.43M
Purchases of Short-Term Investments -58.74M -33.28M -11.97M -186.61M
Other Cash from Investing Activities 3.72M 3.07M 326.00K -93.00K
Cash Provided by Financing Activities
Net Cash From Investing Activities -6.83M 22.76M 40.66M 38.81M
Issuance of Debt 0.00 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 7.23M 1.95M 4.05M 1.93M
Repayment of Long-Term Debt 0.00 -1.08M -1.66M 0.00
Repurchase of Capital Stock -5.16M -7.20M 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 0.00 0.00 -571.00K 0.00
Net Cash From Financing Activities 2.08M -6.33M 1.83M 1.93M
Effect of Exchange Rate Changes -2.07M -1.31M 708.00K 826.00K
Net Change in Cash & Cash Equivalents -28.78M 4.04M -1.50M 39.45M

ELOS Syneron Medical Ltd

Analysts Ratings for ELOS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

ELOS Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs